BiomX raises $24M series A round

Microbiome play BiomX Ltd. (Ness Ziona, Israel) raised $24 million in a series A round led by OrbiMed, the Johnson & Johnson Innovation - JJDC Inc. unit of Johnson & Johnson (NYSE:JNJ), and Takeda Ventures. Also participating were Seventure Partners, MiraeAsset, SBI Japan-Israel Innovation Fund and other undisclosed European investors.

BiomX emerged from Israeli biotech incubator FutuRx Ltd., which the three lead investors established (see BioCentury Innovations, Jan. 16, 2014). ...